Greenberg S D, Fraire A E, Kinner B M, Johnson E H
Pathol Annu. 1987;22 Pt 2:387-405.
From this and other studies, it is clear that the determination of tumor cell type is dependent on cellular and architectural patterns which are fraught with considerable interobserver and even intraobserver variations. Even though determination of cell type is semiobjective at best, previous reports have sought to determine prognosis solely on the basis of cell type or subtype while other studies have made attempts to define the prognosis of the disease based on even less precise terms. In seeking an answer to the question of which is more important for prognosis of lung cancer, cell type or TNM stage, the findings reported herein support the hypothesis that the TNM stage is the single most important factor for survival. This conclusion is substantiated by the following observations: 1. When cell type is stratified by stage, no significant differences can be determined in survival according to tumor cell type. 2. There is a minor difference (not statistically significant) in survival for tumor cell type when considering resected stage I tumors (67 of 99) in terms of adenocarcinomas which had a survival of 38 percent at 5 years versus squamous cell carcinomas which had a survival of 23 percent at 5 years. The numbers of cases in this study were not sufficiently large to comment on the possible difference between surgically resected large cell and small cell carcinomas. 3. TNM staging is a highly significant predictor in the survival of patients with lung cancer. The significance for survival by stage remains even if the data are stratified by the cell type diagnosis. These conclusions apply to the total group of 124 patients, and also to the subgroup of 99 surgically resected patients. Many reports have attempted to determine survival of carcinoma of the lung in terms of cell type without regard to its stage. Consequently, comparison of data from various institutions is difficult. We believe TNM staging of the disease not only allows reasonable comparison of data obtained from different institutions, but also, affords a useful and accurate means of assessing the extent of the disease and its prognosis.
从这项研究以及其他研究可以清楚地看出,肿瘤细胞类型的判定取决于细胞和组织结构模式,而这些模式在不同观察者甚至同一观察者之间都存在相当大的差异。尽管细胞类型的判定充其量只是半客观的,但以往的报告试图仅根据细胞类型或亚型来判定预后,而其他研究则试图用更不精确的术语来界定疾病的预后。在探寻肺癌预后中细胞类型和TNM分期哪个更重要的问题答案时,本文报告的研究结果支持TNM分期是生存的单一最重要因素这一假说。这一结论得到以下观察结果的证实:1. 当按分期对细胞类型进行分层时,根据肿瘤细胞类型无法确定生存方面的显著差异。2. 在考虑I期切除肿瘤(99例中的67例)时,腺癌的5年生存率为38%,鳞状细胞癌的5年生存率为23%,肿瘤细胞类型在生存方面存在微小差异(无统计学意义)。本研究中的病例数量不够多,无法对手术切除的大细胞癌和小细胞癌之间可能存在的差异进行评论。3. TNM分期是肺癌患者生存的高度显著预测指标。即使数据按细胞类型诊断进行分层,分期对生存的意义依然存在。这些结论适用于124例患者的总体组,也适用于99例手术切除患者的亚组。许多报告试图根据细胞类型来判定肺癌的生存情况而不考虑其分期。因此,不同机构数据的比较很困难。我们认为该疾病的TNM分期不仅能使来自不同机构的数据进行合理比较,而且还提供了一种有用且准确的评估疾病范围及其预后的方法。